Prognostic value of tumor-infiltrating lymphocytes (TILs) in Luminal breast cancer: A novel computational method for assessing TILs abundance and spatial distribution patterns [0.03%]
肿瘤浸润淋巴细胞(TILs)在 luminal 型乳腺癌中的预后价值：一种评估 TILs 富集度和空间分布模式的新型计算方法
Xi Cai,Yuying Chen,Qianqian Li et al.
Xi Cai et al.
The prognostic significance of tumor-infiltrating lymphocytes (TILs) in Luminal-type breast cancer remains controversial, primarily due to typically low TIL infiltration levels, methodological inconsistencies in assessment, and insufficient...
Postoperative radiation therapy in localized breast malignant phyllodes tumors: RPA-derived risk model identifies high-benefit subgroups with local control improvement [0.03%]
局部乳腺恶性叶状肿瘤术后放射治疗：基于RPA的危险因素模型识别高受益组以改善局部控制率
Wei-Hong Zheng,Zhi-Qing Long,Jia Kou et al.
Wei-Hong Zheng et al.
Introduction: Breast malignant phyllodes tumors (MPTs) are rare, aggressive neoplasms with high locoregional recurrence rates despite wide-margin resection. Though NCCN recommends postoperative radiation therapy (PORT), i...
Denosumab versus zoledronic acid: analgesic and survival impact of an extended treatment regimen beyond 2 years in breast cancer [0.03%]
Denosumab与Zoledronic酸：2年后继续治疗的止痛和生存影响在乳腺癌中的研究
Ernesto Zecca,Luca Zambelli,Gabriele Tinè et al.
Ernesto Zecca et al.
Background: Zoledronic acid (ZA) and denosumab (Dmab) are the standard of care for bone metastases, but there is no consensus on their long-term use. This study was conducted to evaluate treatment patterns (persistence, c...
The role of body mass index at diagnosis in patients with inflammatory breast cancer [0.03%]
诊断时体质指数在炎性乳腺癌患者中的作用
Kristien Borremans,Ha-Linh Nguyen,Maxim De Schepper et al.
Kristien Borremans et al.
Introduction: Inflammatory Breast Cancer (IBC) is an aggressive presentation of BC present in 1-5 % of all patients with BC. While obesity has been consistently associated with worse prognosis in patients with BC, it is u...
Quantitative angiogenesis-based ultrasound biomarkers for differentiating radiologically challenging breast lesions: Radial scar vs invasive ductal carcinoma [0.03%]
基于血管生成的定量超声生物标志物用于鉴别影像学上难以区分的乳腺病变：放射状瘢痕与浸润性导管癌的区别诊断价值
Soroosh Sabeti,Tanin Adl Parvar,Pouya Metanat et al.
Soroosh Sabeti et al.
Purpose: To investigate the effectiveness of quantitative biomarkers derived from quantitative high-definition microvasculature imaging (qHDMI) for differentiation of radial scar (RS) and invasive ductal carcinoma (IDC). ...
Awareness of modifiable lifestyle risk factors and acceptability of secondary risk reduction services amongst Irish breast cancer survivors and oncology healthcare professionals [0.03%]
爱尔兰乳腺癌幸存者和肿瘤卫生专业人员对可改变的生活方式危险因素及二级风险降低服务的认知和接受度
Clara Steele,Janas M Harrington,Seamus O&#x;Reilly
Clara Steele
Breast cancer is the most common non cutaneous cancer in Irish women. Diagnosis offers a key opportunity to promote lifestyle change. This study assessed awareness of modifiable lifestyle risk factors and acceptability of secondary risk red...
Real-world comparative effectiveness of first-line abemaciclib versus palbociclib in HR+/HER2- metastatic breast cancer: A propensity-matched retrospective analysis [0.03%]
阿贝西利与帕博西利治疗HR+/HER2-转移性乳腺癌的疗效比较：倾向匹配回顾性分析
Cho-Hao Lee,Po-Huang Chen,Hong-Jie Jhou et al.
Cho-Hao Lee et al.
Background: In the first-line treatment of hormone receptor-positive, HER2-negative (HR+/HER2-) metastatic breast cancer (mBC), the comparative effectiveness of different cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) r...
Best practices for communication of prognosis and end-of-life discussions with patients with advanced breast cancer: A report from the advanced breast cancer global alliance [0.03%]
晚期乳腺癌患者预后沟通和终末期讨论的最优方法——来自全球晚期乳腺癌联盟的报告
Lesley Fallowfield,Belinda E Kiely,Luzia Travado et al.
Lesley Fallowfield et al.
Purpose: Navigating prognosis and end-of-life (EoL) communications in advanced breast cancer (ABC) is difficult for healthcare professionals, people with the disease, and their caregivers. Greater multidisciplinary guidan...